期刊文献+

高效液相色谱法测定^(18)F-FDG注射液中氨基聚醚含量 被引量:3

Quantification of Kryptofix2.2.2 in ^(18)F-FDG by HPLC
下载PDF
导出
摘要 采用高效液相色谱法测定了18F-FDG注射液中氨基聚醚(K2.2.2)的含量,并对流动相、流速、检测波长进行了选择,确定检测条件为:V(50mmol/L乙酸铵)∶V(乙腈)=1∶1为流动相,流速为0.5mL/min,检测波长210nm,进样量为10μL。K2.2.2在1~50mg/L浓度范围内线性良好,线性回归方程:y=265 939.4x+7 490.7,相关系数γ=0.999,回收率为96.0%~100.3%,精密度小于3.5%。本方法回收率较高,精密度较小,样品用量少,可用于18F-FDG注射液中微量K2.2.2的测定。 A high-performance liquid chromatograph method was used to quantify Krypto- fix2.2.2 (K2.2.2)in the radiopharmaceutical of 18F-FDG(2-Deoxy-2-[18F] fluoro-D-glucose). A Waters C18 column ( XTerra RP18 150 mm×3. 9 mm,5 μm)was used as stationary phase, V(50 mmol/L ammonium acetate) : V(acetonitrile)=1 : 1 was used as mobile phase and the flow was 0.5 mL · min^-1, UV detection wavelength was performed at 210 nm. The calibration curve was established over the rang of 1-50 mg/L, the linear correlation co- efficient was 0. 999, and the recovery was in the rang of 96.0%-100.3%. The method was accurate and using less sample,and can be used for the quality control of K2.2.2 in 18F-FDG injection production.
出处 《同位素》 CAS 2012年第3期171-174,共4页 Journal of Isotopes
关键词 18F-FDG注射液 氨基聚醚(K2.2.2) 高效液相色谱法 18 F-FDG injection Kryptofix2.2.2 high performance liquid chromatography
  • 相关文献

参考文献6

二级参考文献19

  • 1丁勇,田嘉禾,卫勃,徐白萱,邵明哲,姚树林,尹大一,张书文,刘雁翎.^(18)FDG-PET在直肠、结肠癌诊断中的价值初探[J].同位素,2006,19(3):146-149. 被引量:9
  • 2花宁,陈立光.气相色谱法直接测量^(18)F-FDG中Kryptofix 2.2.2的含量[J].同位素,2007,20(2):105-107. 被引量:14
  • 3Been LB, Suurmeijer A, Cobben D, et al. ^18F- FLT-PET in oncology: current status and opportunities[J]. Eur J Nucl Med Mol Imaging, 2004, 31:1 659-1 672. 被引量:1
  • 4Baudot PH, Jacue M, Robin M. Effect of a diazapolyoxa-macro-bicyclic complexing reagent on the urinary elimination of lead in lead-poisoned rate [J]. Toxicol Appl Pharmacol, 1977, 41: 113-115. 被引量:1
  • 5Chal YT, Da HI JR. Thin layer chromatographic detection of Kryptofix 2.2.2 in the routine synthesis of ^18F-FDG[J]. Nucl Med Biol, 1989, 16: 385-387. 被引量:1
  • 6Garmestani K, Link JM, Krohn KA. Synthesis of tritiated dibotane and cryptand[2.2.2 ] [J]. J Labelled Compounds and Radiopharmaceuticals, 1990, 28(10): 1 171-1 178. 被引量:1
  • 7Kruse MA, Rees SE, Watkins GL. Quality control of Kryptofix or tetrabutyammonium ion in FDG sample by quantitative HPLC analysis proceeding of 47th annual meeting [J]. Nucl Med, 2000, 27(2): 148. 被引量:1
  • 8Ying Ma, Huang BX, Channing MA, et al. Quantification of Kryptofix 2. 2. 2 in 2-^18F-FDG and other radiopharmaceutials by LC/ MS/ MS[J]. Nucl Med Biol, 2002, 29: 125-129. 被引量:1
  • 9CHALY T,DAHL JR.Thin Layer Chromatographic Detection of Kryptofix 2.2.2 in the Routine Synthesis of 18F-FDG[J].Nucl Med Biol,1989,16:385-387. 被引量:1
  • 10MOCK BH,WINKLE W,VAVREK MT.A Color Spot Test for the Detection of Kryptofix2.2.2 in 18F-FDG Preparation[J].Nucl Med Biol,1997,24:193-195. 被引量:1

共引文献15

同被引文献12

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部